Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H7NO3 |
Molecular Weight | 153.1354 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC(O)=C(C=C1)C(O)=O
InChI
InChIKey=WUBBRNOQWQTFEX-UHFFFAOYSA-N
InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)
Molecular Formula | C7H7NO3 |
Molecular Weight | 153.1354 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:06:21 UTC 2023
by
admin
on
Fri Dec 15 15:06:21 UTC 2023
|
Record UNII |
5B2658E0N2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/10/826
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
WHO-ATC |
J04AA01
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
65792
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
LIVERTOX |
42
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
WHO-ATC |
J04AA02
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
220506
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.4
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
WHO-VATC |
QJ04AA01
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
WHO-ATC |
J04AA03
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
37989
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1026401
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
200-613-5
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
2083
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
2050
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
5B2658E0N2
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
D010131
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
113374
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
ALTERNATIVE | |||
|
DB00233
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
m1743
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | Merck Index | ||
|
3203
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
CHEMBL1169
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
27565
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
100000092424
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
Aminosalicylic Acid
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
4649
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
7833
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
SUB12862MIG
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
65-49-6
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
4-AMINOSALICYLIC ACID
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
DTXSID2022591
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY | |||
|
C47394
Created by
admin on Fri Dec 15 15:06:21 UTC 2023 , Edited by admin on Fri Dec 15 15:06:21 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
Correction factors: for the calculation of contents, multiply the peak areas by 1.3
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |